McLaughlin Melissa
SEC insider (Form 3/4/5 filer). CIK 0002127187. Chief Human Resources Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 14 reported Form 4/5 transactions since Sep 2024; latest on Apr 6, 2026. Located in CAMBRIDGE, MA.
Companies McLaughlin Melissa has filed insider reports for
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, Chief Human Resources Officer
McLaughlin Melissa
CIK: 0002127187
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNYLAM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Apr 6, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect56 shares at avg. $320.14$18K - Apr 6, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect909 shares at avg. $329.76$300K - Apr 6, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect829 shares at avg. $330.46$274K - Apr 6, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect293 shares at avg. $331.89$97K - Apr 6, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect199 shares at avg. $333.94$66K - Apr 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect224 shares at avg. $321.64$72K - Apr 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect245 shares at avg. $322.86$79K - Apr 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect265 shares at avg. $316.61$84K - Apr 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect8 shares at avg. $325.49$3K - Apr 2, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect81 shares at avg. $323.64$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 6, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 56 | $320.14 | $17,928 | Direct |
| Apr 6, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 909 | $329.76 | $299,752 | Direct |
| Apr 6, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 829 | $330.46 | $273,951 | Direct |
| Apr 6, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 293 | $331.89 | $97,244 | Direct |
| Apr 6, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 199 | $333.94 | $66,454 | Direct |
| Apr 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 224 | $321.64 | $72,047 | Direct |
| Apr 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 245 | $322.86 | $79,101 | Direct |
| Apr 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 265 | $316.61 | $83,902 | Direct |
| Apr 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 8 | $325.49 | $2,604 | Direct |
| Apr 2, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 81 | $323.64 | $26,215 | Direct |
1-10 of 14 transactions